Skip to main content
. 2018 Jan 4;9(7):7522–7533. doi: 10.18632/oncotarget.23943

Figure 3. ROC curve analysis in different subgroups.

Figure 3

(A) In total enrolled patients, (B) In CA125 normal patients, (C) In CA125 elevated patients. Benign and other malignant patients were considered as the control group, cutoff value of CA125 was considered as 35 U/ml.